Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (900904) — Net Asset Quality Index
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (900904) has a Net Asset Quality Index of 79.5% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $3.00 Billion minus total liabilities of $614.48 Million yields net assets of $2.39 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read 900904 total liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B Net Asset Quality Index Over Time (2015–2024)
This chart shows how Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B's Net Asset Quality Index has evolved across 10 annual periods from 2015 to 2024. As of June 2025, the index stands at 79.5%, representing net assets of $2.39 Billion against total assets of $3.00 Billion USD. For live market cap and overall valuation, see 900904 market cap overview.
Annual Net Asset Quality Index for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (2015–2024)
The table below presents the year-by-year Net Asset Quality Index for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B from 2015 to 2024, covering 10 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Shanghai Shenqi Pharmaceutical Investmen PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 77.9% | $2.43 Billion | $3.12 Billion | $689.01 Million | ▲ +5.0 pp |
| 2023 | 72.9% | $2.39 Billion | $3.28 Billion | $888.77 Million | ▲ +2.9 pp |
| 2022 | 70.0% | $2.37 Billion | $3.39 Billion | $1.01 Billion | ▼ -5.9 pp |
| 2021 | 76.0% | $2.39 Billion | $3.15 Billion | $756.45 Million | ▲ +0.8 pp |
| 2020 | 75.1% | $2.33 Billion | $3.10 Billion | $770.28 Million | ▲ +0.3 pp |
| 2019 | 74.8% | $2.66 Billion | $3.56 Billion | $894.60 Million | ▼ -8.3 pp |
| 2018 | 83.1% | $2.60 Billion | $3.13 Billion | $527.74 Million | ▲ +1.4 pp |
| 2017 | 81.7% | $2.53 Billion | $3.10 Billion | $565.34 Million | ▲ +0.6 pp |
| 2016 | 81.1% | $2.43 Billion | $3.00 Billion | $567.56 Million | ▼ -4.5 pp |
| 2015 | 85.6% | $2.29 Billion | $2.67 Billion | $384.98 Million | — |